Profile data is unavailable for this security.
About the company
Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
- Revenue in EUR (TTM)1.43bn
- Net income in EUR331.80m
- Incorporated2006
- Employees3.82k
- LocationOrion OyjOrionintie 1AESPOO 02200FinlandFIN
- Phone+358 104261
- Fax+358 104264435
- Websitehttps://www.orion.fi/
More ▼
9.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Keskin�inen El�kevakuutusyhti� Ilmarinenas of 21 Jun 2023 | 1.85m | 5.60% |
| Keskin�inen Ty�el�kevakuutusyhti� Eloas of 28 Feb 2023 | 292.80k | 0.89% |
| Guardians of New Zealand Superannuationas of 30 Jun 2023 | 223.39k | 0.68% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 129.07k | 0.39% |
| Jenny ja Antti Wihurin rahasto sras of 28 Feb 2023 | 123.84k | 0.38% |
| Handelsbanken Fonder ABas of 31 Oct 2024 | 119.31k | 0.36% |
| abrdn Investment Management Ltd.as of 31 Jan 2024 | 115.93k | 0.35% |
| Mercer Global Investments Europe Ltd.as of 31 Dec 2023 | 75.06k | 0.23% |
| Nordea Investment Management AB (Denmark)as of 30 Sep 2024 | 49.81k | 0.15% |
| BlackRock Investment Management (UK) Ltd.as of 31 Mar 2024 | 32.43k | 0.10% |
More ▼
Data from 30 Jun 2023 - 30 Sep 2024Source: FactSet Research Systems Inc.
